Introduction

The Innovation Lab for Cancer Prevention and Control (CALab) was initiated in 2025 by the Global Health Research Center at Duke Kunshan University, in collaboration with Beijing Cancer Hospital, Zhongshan Hospital affiliated with Fudan University, Fudan University, and Chinese Center for Disease Control and Prevention.

The lab focuses on key challenges in China’s cancer control system and conducts empirical research on policy design, implementation pathways, and system optimization across prevention, screening, treatment, rehabilitation, and supportive care. It aims to foster multidisciplinary collaboration and cross-sector coordination, promote the translation of evidence into policy and practice, and contribute to the development of a more scientific, equitable, and effective cancer prevention and control system.

Vision

Advancing a fair, accessible, and effective cancer prevention and control system through quality research and evidence-based advocacy—to reduce cancer burden and improve patient outcomes.

Leaders

Prof. Yang Ke

Honorary President, Peking University Cancer Hospital

Prof. Jian Zhou

President, Zhongshan Hospital, Fudan University

Prof. Fan Wu

Vice Dean, Shanghai Medical College, Fudan University

Dr. Jing Wu

Director, Center for Chronic Disease Control and Prevention, Chinese CDC

Prof. Shenglan Tang

Director, Global Health Research Center, Duke Kunshan University

Policy Briefs

News

Closed-Door Roundtable on Building a Cancer Prevention and Control System with Chinese Characteristics

2025-06-05

Frontiers

2025-08-05

北大肿瘤医院柯杨/何忠虎团队在《BJC》发布真实世界研究成果,推动上消化道癌筛查策略优化

2025-07-28

复旦大学中山医院牵头发布《柳叶刀》全球肝癌防治策略与行动计划

2024-11-07

北大肿瘤医院柯杨/何忠虎课题组在《Science Bulletin》发布高等级真实世界证据,支持“医防融合”提升癌症生存

2024-10-16

复旦大学陈英耀教授团队牵头发布首个基于中国视角的PD-L1检测指导NSCLC免疫治疗成本效果研究

Partners

Beijing Cancer Hospital
Zhongshan Hospital
Fudan University
China CDC